does tirzepatide cause decreased libido Sex Drive, Erectile Dysfunction, and GLP-1 Side Effects Thyroid Health & Low Libido

Legal Status of MOUNJARO 7.5mg KwikPen MOUNJARO (tirzepatide) is an FDA-approved prescription-only medicine, manufactured by Eli Lilly and Company Limited [3]

Week 1 after stopping: Drug levels begin decreasing Appetite suppression typically remains strong Week 2: Significant reduction in drug concentration Metabolic effects still present Week 3: Drug levels become low Appetite control may begin decreasing Week 45: Most of the medication is cleared Physiological effects gradually fade This slow elimination helps prevent sudden changes in appetite or blood sugar regulation

10 mg weekly (40 mg total per vial)

they help you tolerate it and hold onto muscle

Appetite (GLP-1) + insulin signaling (GIP) + fullness (amylin)

Clinical evidence consistently shows that weight regain is common when treatment is discontinued without corresponding lifestyle modifications